Treatment of psychopathology in people with intellectual and other disabilities

Canadian Journal of Psychiatry

Volumn 57, Issue 10, 2012, Pages 593-600

  Sturmey, Peter ^a  

^a CITY UNIVERSITY OF NEW YORK   (United States)

Author keywords

Applied behaviour analysis; Autism spectrum disorders; Cognitive therapy; Cognitive behavioural therapy; Intellectual disabilities; Mental retardation; Psychopathology; Psychopharmacology; Psychosocial interventions; Randomized controlled trials

Indexed keywords

ATOMOXETINE; CLOMIPRAMINE; HALOPERIDOL; LITHIUM; NALTREXONE; OLANZAPINE; PLACEBO; RISPERIDONE; ZIPRASIDONE;

ANGER; AUDITORY INTEGRATION THERAPY; AUTISM; BEHAVIOR THERAPY; BIOLOGICAL THERAPY; COGNITIVE THERAPY; COMMUNICATION SKILL; COUNSELING; DEPRESSION; DEVELOPMENTAL DISORDER; FEAR; HUMAN; HYPERACTIVITY; INTELLECTUAL IMPAIRMENT; LEARNING; MENTAL DISEASE; MUSIC THERAPY; OBSESSIVE COMPULSIVE DISORDER; PHOBIA; POSTTRAUMATIC STRESS DISORDER; PSYCHOSOCIAL CARE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REINFORCEMENT; REVIEW; SIDE EFFECT; STEREOTYPY; TREATMENT OUTCOME; WEIGHT GAIN;

EID: 84873040568     PISSN: 07067437     EISSN: 14970015     Source Type: Journal    
DOI: 10.1177/070674371205701003     Document Type: Review

References (94)

1. Deb S, Thomas M, Bright C. Mental disorder in adults with intellectual disability. 2: The rate of behaviour disorders among a community-based population aged between 16 and 64 years. J Intellect Disabil Res. 2001;45(Pt 6):506-514. (Pubitemid 33107572)
2. Smith S, Branford D, Collacott RA, et al. Prevalence and cluster typology of maladaptive behaviors in a geographically defined population of adults with learning disabilities. Br J Psychiatry. 1996;169:219-227.
3. Einfeld SL, Tonge BJ. Population prevalence of psychopathology in children and adolescents with intellectual disability: II. Epidemiological findings. J Intellect Disabil Res. 1996;40(Pt 2):99-109.
4. Underwood L, McCarthy J, Tsakanikos E. Mental health in adults with autism spectrum disorders and intellectual disability. Curr Opin Psychiatry. 2010;23:421-426.
5. Aman MG, Van Bourgondien ME, Wolford PL, et al. Psychotropic and anticonvulsant drugs in subjects with autism: prevalence and patterns of use. J Am Acad Chil Adolesc Psychiatry. 1995;34:1672-1681.
6. Baumeister AA, Todd ME, Sevin JA. Efficacy and specificity of pharmacological therapies for behavioral disorders in persons with mental retardation. Clin Neuropharmacol. 1993;16:271-294. (Pubitemid 23219893)
7. Pyles DAM, Muniz K, Cade A, et al. A behavioral diagnostic paradigm for integrating behavior-analytic and psychopharmacological interventions for people with a dual diagnosis. Res Dev Disabil. 1997;18:185-214. (Pubitemid 27282249)
8. Singh NN, Ellis CR, Wechsler H. Psychopharmacoepidemiology of mental retardation: 1966 to 1995. J Child Adolesc Psychopharmacol. 1997;7:255-266. (Pubitemid 28157325)
9. Sturmey P. It is time to reduce and safely eliminate restrictive behavioural practices. J Intellect Disabil Res. 2009;22:105-110.
10. Sturmey P. Restraint, seclusion and PRN medication in English services for people with learning disabilities administered by the National Health Service: an analysis of the 2007 National Audit survey. J Intellect Disabil Res. 2009;22:140-144.
11. Einfeld SL, Ellis LA, Doran CM, et al. Behavior problems increase cost of care of children with intellectual disabilities. J Ment Health Res Intellect Disabil. 2010;3:202-209.
12. Keller FS, Schoenfeld WN. Principles of psychology. New York (NY): Appleton-Century-Crofts; 1950.
13. Skinner BF. Science and human behavior. New York (NY): MacMillan; 1953.
14. Baer DM, Wolf MM, Risley TR. Some current dimensions of applied behavior analysis. J Appl Behav Anal. 1968;1:91-97.
15. Cooper JO, Heron TE, Heward WL. Applied behavior analysis. 2nd ed. Englewood Cliffs (NJ): Pearson; 2007.
16. Sturmey P. Functional analysis in clinical psychology. Chichester (GB): John Wiley & Sons, Ltd; 1996.
17. Sturmey P. Functional analysis in clinical practice. New York (NY): Elsevier; 2007.
18. Iwata BA, Dorsey, MF, Slifer KJ, et al. Toward a functional analysis of self-injury. J Appl Behav Anal. 1994;27:197-209.
19. Hanley GB, Iwata BA. Functional analysis of problem behavior: a review. J Appl Behav Anal. 1980;36:147-185.
20. Matson JL, Sturmey P. International handbook of autism and pervasive and developmental disabilities. New York (NY): Springer; 2011.
21. Surgeon General. Mental health. A report of the surgeon general. Washington (DC): US Department of Health and Human Services; 1999.
22. Rush AJ, Frances A. The expert consensus guidelines: treatment of psychiatric and behavioral problems in mental retardation. Am J Ment Retard. 2000;105:159-228.
23. Aman MG, Crismon ML, Frances A, et al, editors. Treatment of psychiatric and behavior problems in individuals with mental retardation: an update of the Expert Consensus Guidelines for mental retardation/developmental disability populations. Englewood (CO): Postgraduate Institute for Medicine; 2004.
24. Maffei-Almodovar L, Sturmey P. Evidence-based practice and crisis intervention. In: Reed DD, DiGennaro Reed FD, Luiselli JK, editors. Handbook of crisis intervention for individuals with developmental disabilities. New York (NY): Springer; 2012.
25. Didden R, Duker PC, Korzilius H. Meta-analytic study on treatment effectiveness for problem behaviors with individuals who have mental retardation. Am J Ment Retard. 1997;101:387-399. (Pubitemid 27061357)
26. Didden R, Korzilius H, van Oorsouw W, et al. Behavioral treatment of challenging behaviors in individuals with mild mental retardation: meta-analysis of single-subject research. Am J Ment Retard. 2006;111:290-298. (Pubitemid 44116796)
27. Christiansen E. Effectiveness of behavioral treatments for the reduction of self-injury in autism: a meta-analysis [master's thesis]. [Salt Lake City (UT)]: University of Utah; 2005. Dissertation Abstracts International: Section B: The Sciences and Engineering. 2005;71(1-B):647.
28. Christiansen E. Effectiveness of interventions targeting self-injury in children and adolescents with developmental disabilities: a meta-analysis [dissertation]. Dissertation Abstracts International: Section B: Sciences and Engineering. 2009;71(1-B):647.
29. Sturmey P, Maffei-Almodovar L, Madzharova MS, et al. Selfinjurious behavior. In: Sturmey P, Hersen M, editors. Handbook of evidence-based practice in clinical psychology. Vol 2, Adults. New York (NY): John Wiley & Sons, Ltd; 2012. p 171-195.
30. McAdam D, Breidbord J, Levine A, et al. Pica. In: Hersen M, Sturmey P. Handbook of evidence-based practice in clinical psychology. Vol 1, Children and adolescents. New York (NY): John Wiley & Sons, Ltd; 2012. p 323-338.
31. Jennett HK, Hagopian LP. Identifying empirically supported treatments for phobic avoidance in individuals with intellectual disabilities. Behav Ther. 2008;39:151-161.
32. Sturmey P, Lindsay WR, Vause T, et al. Anxiety disorders. In: Sturmey P, Didden R, editors. Evidence-based practice in intellectual disabilities. Chichester (GB): John Wiley & Sons, Ltd; Forthcoming.
33. Matson JL. Treatment of obsessive compulsive behavior in mentally retarded adults. Behav Mod. 1982;6:551-568.
34. Kuhn DE, Hardesty SL, Sweeney NM. Assessment and treatment of excessive straightening and destructive behavior in an adolescent diagnosed with autism. J Appl Behav Anal. 2009;42:355-360.
35. Sigafoos J, Green VA, Payne D, et al. A classroom-based antecedent intervention reduces obsessive-repetitive behavior in an adolescent with autism. Clin Case Stud. 2009;8:3-13.
36. Berry CL, Schell RM. Reducing hoarding behavior with individualized reinforcement and item return. Behav Interv. 2006;21:123-135.
37. Kostinas G, Scandlen A, Luiselli JK. Effects of DRL and DRL combined with response cost on perseverative verbal behavior of an adult with mental retardation and obsessive compulsive disorder. Behav Interv. 2001;16:27-37. (Pubitemid 32220660)
38. Chambless DL, Hollon SD. Defining empirically supported therapies. J Consult Clin Psych. 1998;66:7-18. (Pubitemid 28086807)
39. Green CW, Reid DH. Defining, validating, and increasing indices of happiness among people with profound multiple disabilities. J Appl Behav Anal. 1996;29:67-78. (Pubitemid 126416796)
40. Green CW, Reid DH. Reducing indices of unhappiness among individuals with profound multiple disabilities during therapeutic exercise routines. J Appl Behav Anal. 1999;32:137-147.
41. Lancioni GE, O'Reilly MF, Singh NN, et al. Impact of stimulation versus microswitch-based programs on indices of happiness of people with profound multiple disabilities. Res Dev Disabil. 2002;23:149-160. (Pubitemid 34308897)
42. Carr EG, Magito McLaughlin D, Giacobbe-Grieco T, et al. Using mood ratings and mood induction in assessment and intervention for severe problem behavior. Am J Ment Retard. 2003;108:32-55.
43. Lindauer SE, DeLeon IG, Fisher WW. Decreasing signs of negative affect and correlated self-injury in an individual with mental retardation and mood disturbances. J Appl Behav Anal. 1999;32:103-106.
44. Matson JL. The treatment of behavioral characteristics of depression in the mentally retarded. Behav Ther. 1982;13:209-218. (Pubitemid 12149729)
45. Matson JL, Dettling J, Senatore V. Treating depression in a mentally retarded adult. Br J Ment Subnorm. 1979;26:86-88.
46. Sturmey P. Suicide threats and behavior in a person with developmental disabilities: effective psychiatric monitoring based on a functional assessment. Behav Interv. 1994;9:235-245.
47. Provencal SC. The efficacy of a social skills training program for adolescents with autism spectrum disorders [dissertation]. Dissertation Abstracts International: Section B: The Sciences and Engineering. 2003;64(3-B):1504.
48. Travis R, Sturmey P. A review of behavioral interventions for psychotic verbal behavior in people with intellectual disabilities. J Ment Health Res Intellect Disabil. 2008;1:33-47.
49. Travis R, Sturmey P. Functional analysis and treatment of the delusional statements of a man with multiple disabilities: a four-year follow-up. J Appl Behav Anal. 2010;43:745-749.
50. Sturmey P. Cognitive therapy for people with intellectual disabilities: a selective review and critique. Clin Psych Psychother. 2004;11:222-232. (Pubitemid 39409600)
51. McCabe MP, McGillivray JA, Newton DC. Effectiveness of treatment programmes for depression among adults with mild/moderate intellectual disability. J Intellect Dis Res. 2006;50(Pt 4):239-247. (Pubitemid 43329501)
52. McGillivray JA, McCabe MP, Kershaw MM. Depression in people with intellectual disability: an evaluation of a staff-administered treatment program. Res Dev Disabil. 2008;29:524-536.
53. Travis R, Hamelin J, Sturmey P. Anger management and intellectual disabilities: a systematic review. J Ment Health Res Intellect Disabil. Forthcoming 2013.
54. Vargas S, Camilli G. A meta-analysis of research on sensory integration treatment. Am J Occup Ther. 1999;53:189-198.
55. Stephenson J, Carter M. The use of weighted vests with children with autism spectrum disorders and other disabilities. J Autism Dev Disord. 2009;39:105-114.
56. Lotan M, Gold C. Meta-analysis of the effectiveness of individual intervention in the controlled multisensory environment (Snoezelen) for individuals with intellectual disability. J Intellect Dev Disabil. 2009;34:207-215.
57. Sinha Y, Silove N, Wheeler D, et al. Auditory integration training and other sound therapies for autism spectrum disorders: a systematic review. Arch Dis Child. 2006;91:1018-1022. (Pubitemid 44863143)
58. Whipple J. Music intervention for children and adolescents with autism: a meta-analysis. J Music Ther. 2004;41:90-108.
59. Gold C, Wigram T, Elefant C. Music therapy for autism spectrum disorder. Cochrane Database Syst Rev. 2006 Apr 19;(2):CD004381.
60. Jesner OD, Aref-Adib M, Coren E. Risperidone for autism spectrum disorder. Cochrane Database Syst Rev. 2007 Jan 24;(1):CD005040.
61. Brylewski J, Duggan L. Antipsychotic medication for challenging behaviour in people with learning disability. Cochrane Database Syst Rev. 2004;(3):CD000377.
62. Siegel M, Beaulieu AA. Psychotropic medications in children with autism spectrum disorders: a systematic review and synthesis for evidence-based practice. J Autism Dev Disord. 2011 Nov 9; [Epub aheard of print].
63. Zuddas A, Zanni R, Usala T. Second generation antipsychotics (SGAs) for non-psychotic disorders in children and adolescents: a review of the randomized controlled studies. Eur Neuropsychopharmacol. 2011;21:600-620.
64. McCracken JT, McGough J, Shah B, et al. Risperidone in children with autism and serious behavioral problems. N Engl J Med. 2002;347:314-321. (Pubitemid 34815353)
65. Hollander E, Wasserman S, Swanson EN, et al. A double-blind placebo-controlled pilot study of olanzapine in childhood/adolescent pervasive developmental disorder. J Child Adolesc Psychopharmacol. 2006;16:541-548. (Pubitemid 44737209)
66. Zarcone JR, Hellings JA, Crandall K, et al. Effects of risperidone on aberrant behavior of persons with developmental disabilities: I. A double-blind crossover study using multiple measures. Am J Ment Retard. 2001;106:525-538. (Pubitemid 34003384)
67. Valdovinos MG, Napolitano DA, Zarcone JR, et al. Multimodal evaluation of risperidone for destructive behavior: functional analysis, direct observations, rating scales, and psychiatric impressions. Exp Clin Psychopharmacol. 2002;10:268-275. (Pubitemid 34919935)
68. Crosland KA, Zarcone JR, Lindauer SE, et al. Use of functional analysis methodology in the evaluation of medication effects. J Autism Dev Disord. 2003;33:271-279. (Pubitemid 36919118)
69. Yoo JH, Williams DC, Napolitano DA, et al. Rate-decreasing effects of the atypical neuroleptic risperidone attenuated by conditions of reinforcement in a woman with mental retardation. J Appl Behav Anal. 2003;36:245-248. (Pubitemid 38613367)
70. De Hert M, Dobbelaere M, Sheridan EM, et al. Metabolic and endocrine adverse effects of second-generation antipsychotics in children and adolescents: a systematic review of randomized, placebo controlled trials and guidelines for clinical practice. Eur Psychiatry. 2011;26:144-158.
71. Sohanpal SK, Deb S, Thomas C, et al. The effectiveness of antidepressant medication in the management of behaviour problems in adults with intellectual disabilities: a systematic review. J Intellect Disabil Res. 2007;51(Pt 10):750-765. (Pubitemid 47371837)
72. Deb S, Sohanpal SK, Soni R, et al. The effectiveness of antipsychotic medication in the management of behaviour problems in adults with intellectual disabilities. J Intellect Disabil Res. 2007;51(Pt 10):766-777. (Pubitemid 47371838)
73. Deb S, Unwin GL. Psychotropic medication for behaviour problems in people with intellectual disability: a review of the current literature. Curr Opin Psychiatry. 2007;20:461-466. (Pubitemid 47356749)
74. Deb S, Chaplin R, Sohanpal S, et al. The effectiveness of mood stabilizers and antiepileptic medication for the management of behaviour problems in adults with intellectual disabilities: a systematic review. J Intellect Disabil Res. 2008;52(Pt 2):107-113.
75. Unwin GL, Deb S. Efficacy of atypical antipsychotic medication in the management of behaviour problems in children with intellectual disabilities and borderline intelligence: a systematic review. Res Dev Disabil. 2011;32:2121-2133.
76. Singh AN, Matson JL, Cooper CL, et al. The use of risperidone among individuals with mental retardation: clinically supported or not? Res Dev Disabil. 2005;26:203-218. (Pubitemid 40164203)
77. Aman MG, McDougle CJ, Scahill L, et al. Medication and parent training in children with pervasive developmental disorders and serious behavior problems: results from a randomized clinical trial. J Am Acad Child Adolesc Psychiatry. 2009;48:1143-1154.
78. Gagiano C, Read S, Thorpe L, et al. Short- and long-term efficacy and safety of risperidone in adults with disruptive behavior disorders. Psychopharmacology (Berl). 2005;179:629-636. (Pubitemid 40674764)
79. Lewis MH, Bodfish JW, Powell SB, et al. Clomipramine treatment for self-injurious behavior of individuals with mental retardation: a double-blind comparison with placebo. Am J Ment Retard. 1996;100:654-665. (Pubitemid 26180474)
80. Tyrer SP, Walsh A, Edwards DE, et al. Factors associated with a good response to lithium in aggressive mentally handicapped subjects. Prog Neuropsychopharmacol Biol Psychiatry. 1984;8:751-755. (Pubitemid 15193241)
81. Romeo R, Knapp M, Tyrer P, et al. The treatment of challenging behaviour in intellectual disabilities: cost-effectiveness analysis. J Intellect Disabil Res. 2009;53:633-643.
82. Einfeld S, Tonge B, Chapman L, et al. Inter-rater reliability of the diagnoses of psychosis and depression in individuals with intellectual disabilities. J Appl Res Intellect Disabil. 2007;20:384-390.
83. Courtemanche AB, Schroeder SR, Sheldon JB. Designs and analyses of psychotropic and behavioral interventions for the treatment of problem behavior among people with intellectual and developmental disabilities. Am J Intellect Dev Disabil. 2011;116:315-328.
84. Poling A, LeSage M. Evaluating psychotropic drugs in people with mental retardation: where are the social validity data? Am J Ment Retard. 1995;100:193-200.
85. Kern L, Vorndran CM, Hilt A, et al. Choice as an intervention to improve behavior: a review of the literature. J Behav Educ. 1998;8:151-169.
86. Shogren KA, Faggella-Luby MN. The effect of choice-making as an intervention for problem behavior: a meta-analysis. J Posit Behav Interv. 2004;6:228-237. (Pubitemid 39374522)
87. Mancil GR. Functional communication training: a review of the literature related to children with autism. Educ Train Dev Disabil. 2006;41:213-224.
88. Banda DR, Grimmett E. Enhancing social and transition behaviors of persons with autism through activity schedules: a review. Educ Train Dev Disabil. 2008;43:324-333.
89. Bellini S, Akullian J. A meta-analysis of video modeling and video self-monitoring interventions for children and adolescents with autism spectrum disorders. Except Child. 2007;73:264-287.
90. Carr EG, Horner RH, Turnbull AP, et al. Positive behavior support for people with developmental disabilities. A research synthesis. Washington (DC): American Association on Mental Retardation; 1999.
91. Rispoli M, Neely L, Lang R, et al. Training paraprofessionals to implement interventions for people with autism spectrum disorders: a systematic review. Dev Neurorehabil. 2011;14(6):378-388.
92. Wood AL, Luiselli JK, Harchik AE. Training instructional skills with paraprofessional service providers at a community-based habilitation setting. Behav Modif. 2011;31:847-855.
93. Hassiotis A, Robotham D, Canagasabey A, et al. Randomized, single-blind, controlled trial of a specialist behavior therapy team for challenging behavior in adults with intellectual disabilities. Am J Psychiatry. 2009;166:1278-1285.
94. Hassiotis A, Robotham D, Canagasabey A, et al. Brief report: impact of applied behaviour analysis (ABA) on carer burden and community participation in challenging behaviour: results from a randomised controlled trial. J Intellect Disabil Res. 2012;56:285-290.